Ferzin Sethna
About Ferzin Sethna
Ferzin Sethna is a Principal Scientist and Group Lead at Asklepios BioPharmaceutical, Inc., with extensive experience in gene therapy and animal model research. He has previously held positions at institutions such as Michigan State University, SwanBio Therapeutics, and Princeton University, and he advocates for ethical research practices and science education.
Work at Asklepios BioPharmaceutical
Ferzin Sethna currently serves as Principal Scientist and Group Lead at Asklepios BioPharmaceutical, Inc. (AskBio) in Philadelphia, Pennsylvania. He has held this position since 2024. Prior to this role, he worked as a Senior Scientist in Product Development at AskBio from 2021 to 2024. His work focuses on advancing gene therapy applications through next-generation AAV vector improvements and design.
Education and Expertise
Ferzin Sethna holds a Doctor of Philosophy (Ph.D.) in Genetics and Neuroscience from Michigan State University, where he studied from 2009 to 2014. He also earned a Master of Science (MSc) in Biochemistry from The Maharaja Sayajirao University of Baroda, completing his studies from 2006 to 2008. Additionally, he obtained a Bachelor of Science (BSc) in Life Sciences and Biochemistry from St. Xavier's College from 2003 to 2006. His expertise includes next-generation AAV vector design and rodent animal models for neurological and cardiovascular disease research.
Background
Ferzin Sethna has a diverse professional background in the field of biomedical research. He worked as a Postdoctoral Researcher at both Michigan State University and the Perelman School of Medicine at the University of Pennsylvania in 2015. From 2015 to 2019, he served as a Research Scientist at Princeton University. He also held the position of Principal Scientist in Vector Engineering/Translational Sciences at SwanBio Therapeutics from 2019 to 2021.
Achievements
Throughout his career, Ferzin Sethna has made significant contributions to the field of gene therapy and biomedical research. He has a strong background in due diligence and contract management, which is essential for overseeing complex research projects. He is also an advocate for animal welfare, demonstrating a commitment to ethical research practices, and is passionate about promoting science education and communication.